Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapy.
CONCLUSION: a 3.5 cm-wide HRCZ is a reliable LADCA surrogate for breast radiotherapy. Applying maximum dose constraints to the HRCZ could limit LADCA exposure. Auto-segmentation algorithms can reliably delineate HRCZ.
PMID: 33007352 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Loap P, Tkatchenko N, Nicolas E, Fourquet A, Kirova Y Tags: Radiother Oncol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cardiology | Heart | Heart Disease | Intensity-Modulated Radiation Therapy | Radiology | Study